Nestifylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161549This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C11H14N4O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 52915ASM3D, chemically known as 3,7-dihydro-1,3-dimethyl-7-(1,3-dithiolan-2-ylmethyl)-1h-purine-2,6-dione but generally known as nestifylline, which bears US NIH Compound Identifier 65931. European Medicines Agency schedules Nestifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09209MIG. The term NESTIFYLLINE is an International Non-Proprietary Name. NESTIFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nestifylline under HS 29395900 and SITC 54145. As of Q4 2014, NESTIFYLLINE remains the US FDA Preferred Term for this commodity. Nestifylline bears US NLM identifiers UMLS ID C1882069 and NCI Concept Code C66234. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3SCCS3.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.